Arcus Biosciences
RCUS
RCUS
186 hedge funds and large institutions have $763M invested in Arcus Biosciences in 2025 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 98 increasing their positions, 29 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.16% more ownership
Funds ownership: 91.69% → 91.85% (+0.16%)
39% less capital invested
Capital invested by funds: $1.25B → $763M (-$486M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
186
Holding in Top 10
1
Calls
$1.09M
Puts
$1.03M
Top Buyers
| 1 | +$15.6M | |
| 2 | +$12.6M | |
| 3 | +$10.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.2M |
| 5 |
BlackRock
New York
|
+$9.21M |
Top Sellers
| 1 | -$23.9M | |
| 2 | -$11.9M | |
| 3 | -$10.9M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.6M |
| 5 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
-$5.23M |